Expression of a neuroendocrine gene signature in gastric tumor cells from CEA 424-SV40 large T antigen-transgenic mice depends on SV40 large T antigen

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Ihler, Fritz ^a,b   Vetter, Elena Viviana ^a   Pan, Jie ^a   Kammerer, Robert ^c   Debey Pascher, Svenja ^d   Schultze, Joachim L ^d   Zimmermann, Wolfgang ^a   Enders, Georg ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

^d UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; PROTEIN P53; SEROTONIN; SMALL INTERFERING RNA; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN; VIRUS LARGE T ANTIGEN; CARCINOEMBRYONIC ANTIGEN; VIRUS T ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INCIDENCE; CELL LINE; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENETIC ASSOCIATION; IN VITRO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PROTEIN FUNCTION; SIMIAN VIRUS 40; STEM CELL; STOMACH TUMOR; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; VIRUS CELL TRANSFORMATION; ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; NEUROENDOCRINE TUMOR; PATHOLOGY; PROMOTER REGION; TUMOR CELL LINE; ULTRASTRUCTURE;

MURINAE; MUS; MUS MUSCULUS;

ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; ANTIGENS, VIRAL, TUMOR; CARCINOEMBRYONIC ANTIGEN; CELL LINE, TUMOR; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, TRANSGENIC; NEUROENDOCRINE TUMORS; PHENOTYPE; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSCRIPTOME;

EID: 84855833394     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029846     Document Type: Article

References (40)

1. Ahuja D, Saenz-Robles MT, Pipas JM, (2005) SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene 24: 7729-7745.
2. Saenz Robles MT, Pipas JM, (2009) T antigen transgenic mouse models. Semin Cancer Biol 19: 229-235.
3. Furth PA, (1998) SV40 rodent tumour models as paradigms of human disease: transgenic mouse models. Dev Biol Stand 94: 281-287.
4. Syder AJ, Karam SM, Mills JC, Ippolito JE, Ansari HR, et al. (2004) A transgenic mouse model of metastatic carcinoma involving transdifferentiation of a gastric epithelial lineage progenitor to a neuroendocrine phenotype. Proc Natl Acad Sci U S A 101: 4471-4476.
5. Ulanet DB, Hanahan D, (2010) Loss of p19(Arf) Facilitates the Angiogenic Switch and Tumor Initiation in a Multi-Stage Cancer Model via p53-Dependent and Independent Mechanisms. PLoS ONE 5: e12454.
6. Chiaverotti T, Couto SS, Donjacour A, Mao JH, Nagase H, et al. (2008) Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer. Am J Pathol 172: 236-246.
7. Reiner T, de las Pozas A, Parrondo R, Perez-Stable C, (2007) Progression of Prostate Cancer from a Subset of p63-Positive Basal Epithelial Cells in FG/Tag Transgenic Mice. Mol Cancer Res 5: 1171-1179.
8. Gum JR Jr, Hicks JW, Crawley SC, Yang SC, Borowsky AD, et al. (2004) Mice expressing SV40 T antigen directed by the intestinal trefoil factor promoter develop tumors resembling human small cell carcinoma of the colon. Mol Cancer Res 2: 504-513.
9. Czeh M, Loddenkemper C, Shalapour S, Schon C, Robine S, et al. (2010) The immune response to sporadic colorectal cancer in a novel mouse model. Oncogene 29: 6591-6602.
10. Vinik AI, Woltering EA, Warner RR, Caplin M, O'Dorisio TM, et al. (2010) NANETS consensus guidelines for the diagnosis of neuroendocrine tumor. Pancreas 39: 713-734.
11. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S, (2010) The Pathologic Classification of Neuroendocrine Tumors: A Review of Nomenclature, Grading, and Staging Systems. Pancreas 39: 707-712.
12. Thompson J, Epting T, Schwarzkopf G, Singhofen A, Eades-Perner AM, et al. (2000) A transgenic mouse line that develops early-onset invasive gastric carcinoma provides a model for carcinoembryonic antigen-targeted tumor therapy. Int J Cancer 86: 863-869.
13. Nockel J, van den Engel NK, Winter H, Hatz RA, Zimmermann W, et al. (2006) Characterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene. BMC Cancer 14: 57.
14. Thompson JA, Eades-Perner AM, Ditter M, Muller WJ, Zimmermann W, (1997) Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy. Int J Cancer 72: 197-202.
15. Hofsli E, (2006) Genes involved in neuroendocrine tumor biology. Pituitary 9: 165-178.
16. Rindi G, Leiter AB, Kopin AS, Bordi C, Solcia E, (2004) The "Normal" Endocrine Cell of the Gut: Changing Concepts and New Evidences. Ann N Y Acad of Sci 1014: 1-12.
17. van der Flier LG, Clevers H, (2009) Stem cells, self-renewal, and differentiation in the intestinal epithelium. Annu Rev Physiol 71: 241-260.
18. Chi P, Chen Y, Zhang L, Guo X, Wongvipat J, et al. (2010) ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours. Nature 467: 849-853.
19. Cantalupo PG, Saenz-Robles MT, Rathi AV, Beerman RW, Patterson WH, et al. (2009) Cell-type specific regulation of gene expression by simian virus 40 T antigens. Virology 386: 183-191.
20. Hulleman E, Quarto M, Vernell R, Masserdotti G, Colli E, et al. (2009) A role for the transcription factor HEY1 in glioblastoma. J Cell Mol Med 13: 136-146.
21. Feuchter AE, Mager DL, (1992) SV40 large T antigen trans-activates the long terminal repeats of a large family of human endogenous retrovirus-like sequences. Virology 187: 242-250.
22. Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, et al. (2007) Directly Reprogrammed Fibroblasts Show Global Epigenetic Remodeling and Widespread Tissue Contribution. Cell Stem Cell 1: 55-70.
23. Barker N, Huch M, Kujala P, van de WM, Snippert HJ, et al. (2010) Lgr5(+ve) Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro. Cell Stem Cell 6: 25-36.
24. Gasi D, van der Korput HA, Douben HC, de Klein A, de Ridder CM, et al. (2011) Overexpression of Full-Length ETV1 Transcripts in Clinical Prostate Cancer Due to Gene Translocation. PLoS ONE 6: e16332.
25. Sun Y, Niu J, Huang J, (2009) Neuroendocrine differentiation in prostate cancer. Am J Transl Res 1: 148-162.
26. Barker N, Ridgway RA, van Es JH, van de Wetering M, Begthel H, et al. (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457: 608-611.
27. Feng H, Shuda M, Chang Y, Moore PS, (2008) Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma. Science 319: 1096-1100.
28. Rockville Merkel Cell Carcinoma Group (2009) Merkel cell carcinoma: recent progress and current priorities on etiology, pathogenesis, and clinical management. J Clin Oncol 27: 4021-4026.
29. Houben R, Shuda M, Weinkam R, Schrama D, Feng H, et al. (2010) Merkel Cell Polyomavirus-Infected Merkel Cell Carcinoma Cells Require Expression of Viral T Antigens. J Virol 84: 7064-7072.
30. Schaffer BE, Park K-S, Yiu G, Conklin JF, Lin C, et al. (2010) Loss of p130 Accelerates Tumor Development in a Mouse Model for Human Small-Cell Lung Carcinoma. Cancer Res 70: 3877-3883.
31. Berman SD, Calo E, Landman AS, Danielian PS, Miller ES, et al. (2008) Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage. Proc Natl Acad Sci U S A 105: 11851-11856.
32. Zhou Z, Flesken-Nikitin A, Corney DC, Wang W, Goodrich DW, et al. (2006) Synergy of p53 and Rb Deficiency in a Conditional Mouse Model for Metastatic Prostate Cancer. Cancer Res 66: 7889-7898.
33. Hiroshima K, Iyoda A, Shibuya K, Haga Y, Toyozaki T, et al. (2004) Genetic alterations in early-stage pulmonary large cell neuroendocrine carcinoma. Cancer 100: 1190-1198.
34. Jiang Z, Deng T, Jones R, Li H, Herschkowitz JI, et al. (2010) Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status. J Clin Invest 120: 3296-3309.
35. Lin PP, Pandey MK, Jin F, Raymond AK, Akiyama H, et al. (2009) Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice. Carcinogenesis 30: 1789-1795.
36. Vooijs M, te Riele H, van der Valk M, Berns A, (2002) Tumor formation in mice with somatic inactivation of the retinoblastoma gene in interphotoreceptor retinol binding protein-expressing cells. Oncogene 21: 4635-4645.
37. Willimsky G, Blankenstein T, (2005) Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance. Nature 437: 141-146.
38. Gentleman R, Carey V, Bates D, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
39. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
40. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.